Cover Image
市場調查報告書

全球微流體設備系統市場-產業分析、市場規模、佔有率、成長、趨勢與預測

Microfluidic Device System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

出版商 Transparency Market Research 商品編碼 304352
出版日期 內容資訊 英文 106 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球微流體設備系統市場-產業分析、市場規模、佔有率、成長、趨勢與預測 Microfluidic Device System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日期: 2014年05月14日 內容資訊: 英文 106 Pages
簡介

微流體,具許多分析用途及商業性的可能性,發展性的科學領域。微流體設備,在醫藥品,細胞生物學研究及蛋白質晶體化等領域中,有數個用途。以這種方式,微流體技術為削減副作用,增強治療效果的重要工具。還有在其他的領域中,藥品的篩檢、砂糖的實驗設備、化學微反應器、微處理器冷卻及超小型燃料電池等,許多的應用案例。

本報告提供全球微流體設備系統市場現況與展望調查分析、市場估計實際成果及預測、市場推動與阻礙成長要素分析、各材料、產業、用途、地區的市場分析,再加上主要企業簡介。

第1章 序

  • 調查的說明
  • 調查手法
    • 資訊來源

第2章 摘要整理

第3章 產業分析

  • 簡介
  • 推動市場成長要素與市場機會
    • 對重點照護檢驗的需求擴大
    • 晶片的小型化削減檢驗成本
    • 基因學及蛋白質體學的微流體設備的需求擴大
    • 材料混合的變化市場對新加入廠商出示新機會
  • 阻礙市場成長要素與課題
    • 嚴格法規必要條件
    • 微流體的相關課題的幾何學、界面化學

第4章 市場趨勢

  • 聯盟、夥伴關係數量的增加
  • 產品革新數量的增加

第5章 波特的五力分析

第6章 全球市場規模與預測

第7章 市場區隔分析:各材料

  • 玻璃
  • 聚合物

第8章 市場區隔分析:各產業

  • 體外診斷
  • 醫藥品
  • 醫療設備

第9章 市場區隔分析:各用途

  • 重點照護檢驗
  • 醫藥品、生命科學研究
  • 藥物研發
  • 分析設備
  • 臨床、獸醫診斷
  • 環境、產業

第10章 各地區分析

  • 北美
  • 歐洲
  • 亞洲
  • 其他地區

第11章 競爭環境

第12章 企業簡介(概要、產品、部門、業績、策略性發展)

  • Roche Diagnostics
  • Abbott Laboratories
  • Siemens Healthcare
  • Agilent Technologies Inc
  • Fluidigm Corporation
  • Bio- Rad Laboratories
  • Cepheid
  • RainDance Technologies
  • Dolomite Centre
  • Micronit Microfluidics
  • Johnson & Johnson
  • Becton, Dickinson and Company
目錄

Microfluidics is an evolving scientific field with numerous analytical applications and commercial potential. Microfluidic devices have several applications in the field of medicine, cell biology research and protein crystallization. Thus, microfluidic technology is an important tool to reduce side effects and improve the efficacy of treatments. It has many applications in other areas such as drug screening, sugar testers, chemical micro reactor, microprocessor cooling and micro fuel cells. Rising demand for point of care testing, miniaturization of chip, and increasing demand for microfluidic devices in genomics and proteomics are the key growth drivers for the microfluidic device market. In addition, change in material mix would provide opportunity for new market entrants, which would further drive the growth of the microfluidic device market.

On the other hand, strict regulatory requirements are a major concern for the industry. Safety, performance and consistent quality of medical devices are a necessity for public health. Thus, it leads to strict and complex regulations and standards for global affiliation of medical devices. In addition, major challenges faced by the microfluidic devices industry are the geometrical and surface chemistry issues during manufacturing of a device.

This report provides an in-depth analysis of estimation of the microfluidic device market for the period 2014-2019, considering 2013 as the base year for calculation. In addition, data pertaining to current market dynamics including market drivers, restraints, trends and strategic developments has been provided in the report. The microfluidic device market is categorized on the basis of material used for manufacturing microfluidic devices, industry, application and geography. Based on industry, the microfluidic device market comprises in-vitro diagnostics, pharmaceuticals and medical devices. The application market comprises point of care testing, analytical devices, pharmaceutical and life science research, clinical and veterinary diagnostics, drug delivery and environment and industry.

In the geographical analysis, the report identifies and analyses market size and forecast of North America, Europe, Asia and Rest of the World (Row). Some of the major players in the microfluidic device market are Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Agilent Technologies, Bio-Rad Laboratories, Fluidigm Corporation, Johnson & Johnson, Becton Dickinson and Company, and others. These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability, and financial overview.

Table of Contents

Chapter 1 Preface

  • 1.1 Report Description
  • 1.2 Research Methodology
    • 1.2.1 Sources
      • 1.2.1.1 Secondary Research
      • 1.2.1.2 Primary Research
      • 1.2.1.3 Assumptions

Chapter 2 Executive Summary

Chapter 3 Industry Analysis

  • 3.1 Introduction
  • 3.2 Market Drivers and Opportunities
    • 3.2.1 Rising demand for point of care testing
    • 3.2.2 Miniaturization of chips, reduces cost of testing
    • 3.2.3 Increasing demand of microfluidic device in genomics and proteomics
    • 3.2.4 Change in material mix provides new opportunities for new players in the market
  • 3.3 Restraints and Challenges
    • 3.3.1 Strict regulatory requirements
    • 3.3.2 Geometrical and surface chemistry issues are a challenge for microfluidics

Chapter 4 Market Trends

  • 4.1 Rising number of collaborations and partnerships
  • 4.2 Rising number of product innovations

Chapter 5 Porters Five Force Analysis

  • 5.1 Bargaining power of buyers
  • 5.2 Bargaining power of suppliers
  • 5.3 Threat of new entrants
  • 5.4 Threat of substitutes
  • 5.5 Degree of competition

Chapter 6 Global Market Size and Forecast

Chapter 7 Segment Analysis - by Material

  • 7.1 Glass
  • 7.2 Polymer
  • 7.3 Silicon

Chapter 8 Segment Analysis - by Industry

  • 8.1 In-vitro diagnostics
  • 8.2 Pharmaceuticals
  • 8.3 Medical Devices

Chapter 9 Segment Analysis - by Application

  • 9.1 Point of care testing
  • 9.2 Pharmaceutical and life science research
  • 9.3 Drug delivery
  • 9.4 Analytical devices
  • 9.5 Clinical and veterinary diagnostics
  • 9.6 Environment and Industrial

Chapter 10 Regional Analysis

  • 10.1 North America
  • 10.2 Europe
  • 10.3 Asia
  • 10.4 Rest of the World

Chapter 11 Competitive Landscape

Chapter 12 Company Profiles

  • 12.1 Roche Diagnostics
    • 12.1.1 Overview
    • 12.1.2 Products and segment
    • 12.1.3 Financial Performance
    • 12.1.4 Strategic Development
  • 12.2 Abbott Laboratories
    • 12.2.1 Overview
    • 12.2.2 Products and segment
    • 12.2.3 Financial Performance
    • 12.2.4 Strategic Developments
  • 12.3 Siemens Healthcare
    • 12.3.1 Overview
    • 12.3.2 Products and segment
    • 12.3.3 Financial Performance
    • 12.3.4 Strategic Development
  • 12.4 Agilent Technologies Inc
    • 12.4.1 Overview
    • 12.4.2 Products and segment
    • 12.4.3 Financial Performance
  • 12.5 Fluidigm Corporation
    • 12.5.1 Overview
    • 12.5.2 Products and segment
    • 12.5.3 Financial Performance
    • 12.5.4 Strategic Developments
  • 12.6 Bio- Rad Laboratories
    • 12.6.1 Overview
    • 12.6.2 Products and segment
    • 12.6.3 Financial Performance
    • 12.6.4 Strategic Developments
  • 12.7 Cepheid
    • 12.7.1 Overview
    • 12.7.2 Products and segment
    • 12.7.3 Financial Performance
    • 12.7.4 Strategic Developments
  • 12.8 RainDance Technologies
    • 12.8.1 Overview
    • 12.8.2 Products and segment
    • 12.8.3 Financial Performance
    • 12.8.4 Strategic Development
  • 12.9 Dolomite Centre
    • 12.9.1 Overview
    • 12.9.2 Products and segment
    • 12.9.3 Financial Performance
    • 12.9.4 Strategic Developments
  • 12.10 Micronit Microfluidics
    • 12.10.1 Overview
    • 12.10.2 Products and segment
    • 12.10.3 Financial Performance
  • 12.11 Johnson & Johnson
    • 12.11.1 Overview
    • 12.11.2 Product Segment
    • 12.11.3 Financial Performance
  • 12.12 Becton, Dickinson and Company
    • 12.12.1 Overview
    • 12.12.2 Products and Segments
    • 12.12.3 Financial performance
    • 12.12.4 Strategic Developments

List of Figures

  • FIG. 1 Applications of Microfluidics
  • FIG. 2 Functions of Microfluidics
  • FIG. 3 Aging population in major regions (% 2000-2050)
  • FIG. 4 Microfluidic Device Market: Porters Five Force Analysis
  • FIG. 5 Global microfluidic device market, by region 2013 (% share)
  • FIG. 6 Global microfluidic device market, by material 2013 (% share)
  • FIG. 7 Global microfluidic device market, by industry 2013 (% share)
  • FIG. 8 Global microfluidic device market, by application 2013 (% share)
  • FIG. 9 Glass microfluidic device market, by region 2013 (% share)
  • FIG. 10 Polymer microfluidic device market, by region 2013 (% share)
  • FIG. 11 Silicon microfluidic device market, by region 2013 (% share)
  • FIG. 12 In-vitro diagnostics industry in microfluidic device market, by region 2013 (% share)
  • FIG. 13 Pharmaceutical industry in microfluidic device market, by region 2013 (% share)
  • FIG. 14 Pharmaceutical industry in microfluidic device market, by product 2013 (% share)
  • FIG. 15 Chips for lab analytics in microfluidic device market, by product 2013 (% share)
  • FIG. 16 Medical device industry in microfluidic device market, by region 2013 (% share)
  • FIG. 17 Medical devices industry in microfluidic device market, by product 2013 (% share)
  • FIG. 18 Microfluidic device material used in point of care testing in 2010 (% share)
  • FIG. 19 Point of care testing in microfluidic device market, by region 2013 (% share)
  • FIG. 20 Microfluidic device material in pharmaceutical and life science research in 2010 (% share)
  • FIG. 21 Pharmaceutical and life science research in microfluidic device market, by region 2013 (% share)
  • FIG. 22 Microfluidic device material in drug delivery in 2010 (% share)
  • FIG. 23 Drug delivery in microfluidic device market, by region 2013 (% share)
  • FIG. 24 Microfluidic device material in analytical devices in 2010 (% share)
  • FIG. 25 Analytical Devices in microfluidic device market, by region 2013 (% share)
  • FIG. 26 Microfluidic device material used in clinical and veterinary diagnosis in 2010 (% share)
  • FIG. 27 Clinical and veterinary diagnosis in microfluidic device market, by region 2013 (% share)
  • FIG. 28 Microfluidic device material in environment and industrial application in 2010 (% share)
  • FIG. 29 Environment and industrial application in microfluidic device market, by region 2013 (% share)
  • FIG. 30 The North American microfluidic device market, by country 2013 (% share)
  • FIG. 31 The European microfluidic device market, by country 2013 (% share)
  • FIG. 32 The Asian microfluidic device market, by country 2013 (% share)
  • FIG. 33 Competitive landscape of global microfluidic device market
  • FIG. 34 Roche sales and net income 2011-2013 (USD Million)
  • FIG. 35 Abbott Laboratories net sales and net earnings 2011-2013 (USD Million)
  • FIG. 36 Siemens revenue and net income 2011-2013 (USD Million)
  • FIG. 37 Agilent Technologies revenue and net income 2011-2013 (USD Million)
  • FIG. 38 Fluidigm Corporation total revenue and net income 2011-2013 (USD Million)
  • FIG. 39 Bio-Rad Laboratories net sales and net income 2010-2012 (USD Million)
  • FIG. 40 Cepheid sales and net income 2011-2013 (USD Million)
  • FIG. 41 Johnson & Johnson sales and net earnings 2011-2013 (USD Million)
  • FIG. 42 Becton, Dickinson and Company revenue and net income 2011-2013 (USD Million)

List of Tables

  • TABLE 1 Market Snapshot: microfluidic device market (2013 & 2019)
  • TABLE 2 Drivers for microfluidic devices market: Impact analysis
  • TABLE 3 Restraints for microfluidic devices market: Impact analysis
  • TABLE 4 Major collaborations and partnerships by microfluidic device companies (2011-2013)
  • TABLE 5 Some of the products launched by various companies
  • TABLE 6 Global microfluidic devices market size, by region 2009-2012 (USD million)
  • TABLE 7 Global microfluidic devices market size, by region 2013-2019 (USD million)
  • TABLE 8 Global microfluidic devices market size, by material 2009-2012 (USD million)
  • TABLE 9 Global microfluidic devices market size, by material 2013-2019 (USD million)
  • TABLE 10 Global microfluidic devices market size, by industry 2009-2012 (USD million)
  • TABLE 11 Global microfluidic devices market size, by industry 2013-2019 (USD million)
  • TABLE 12 Global microfluidic devices market size, by application 2009-2012 (USD million)
  • TABLE 13 Global microfluidic devices market size, by application 2013-2019 (USD million)
  • TABLE 14 Glass microfluidic devices market size, by region 2009-2012 (USD million)
  • TABLE 15 Glass microfluidic devices market size, by region 2013-2019 (USD million)
  • TABLE 16 Polymer microfluidic devices market size, by region 2009-2012 (USD million)
  • TABLE 17 Polymer microfluidic devices market size, by region 2013-2019 (USD million)
  • TABLE 18 Silicon microfluidic devices market size, by region 2009-2012 (USD million)
  • TABLE 19 Silicon microfluidic devices market size, by region 2013-2019 (USD million)
  • TABLE 20 In-vitro diagnostic industry in microfluidic devices market size, by region 2009-2012 (USD million)
  • TABLE 21 In-vitro diagnostic industry in microfluidic devices market size, by region 2013-2019 (USD million)
  • TABLE 22 Pharmaceutical industry in microfluidic devices market size, by region 2009-2012 (USD million)
  • TABLE 23 Pharmaceutical industry in microfluidic devices market size, by region 2013-2019 (USD million)
  • TABLE 24 Pharmaceutical industry in microfluidic devices market size, by products 2009-2012 (USD million)
  • TABLE 25 Pharmaceutical industry in microfluidic devices market size, by products 2013-2019 (USD million)
  • TABLE 26 Chips for lab analytics in microfluidic devices market size, by products 2009-2012 (USD million)
  • TABLE 27 Chips for lab analytics in microfluidic devices market size, by products 2013-2019 (USD million)
  • TABLE 28 Medical devices industry in microfluidic devices market size, by region 2009-2012 (USD million)
  • TABLE 29 Medical devices industry in microfluidic devices market size, by region 2013-2019 (USD million)
  • TABLE 30 Medical devices industry in microfluidic devices market size, by products 2009-2012 (USD million)
  • TABLE 31 Medical devices industry in microfluidic devices market size, by products 2013-2019 (USD million)
  • TABLE 32 Point of care testing in microfluidic devices market size, by region 2009-2012 (USD million)
  • TABLE 33 Point of care testing in microfluidic devices market size, by region 2013-2019 (USD million)
  • TABLE 34 Pharmaceutical and life science research in microfluidic devices market size, by region 2009-2012 (USD million)
  • TABLE 35 Pharmaceutical and life science research in microfluidic devices market size, by region 2013-2019 (USD million)
  • TABLE 36 Drug delivery in microfluidic devices market size, by region 2009-2012 (USD million)
  • TABLE 37 Drug delivery in microfluidic devices market size, by region 2013-2019 (USD million)
  • TABLE 38 Analytical devices in microfluidic devices market size, by region 2009-2012 (USD million)
  • TABLE 39 Analytical devices in microfluidic devices market size, by region 2013-2019 (USD million)
  • TABLE 40 Clinical and veterinary diagnostics in microfluidic devices market size, by region 2009-2012 (USD million)
  • TABLE 41 Clinical and veterinary diagnostics in microfluidic devices market size, by region 2013-2019 (USD million)
  • TABLE 42 Environment and industrial application in microfluidic devices market size, by region 2009-2012 (USD million)
  • TABLE 43 Environment and industrial application in microfluidic devices market size, by region 2013-2019 (USD million)
  • TABLE 44 The North American microfluidic devices market size, by country 2009-2012 (USD million)
  • TABLE 45 The North American microfluidic devices market size, by country 2013-2019 (USD million)
  • TABLE 46 The European microfluidic devices market size, by country 2009-2012 (USD million)
  • TABLE 47 The European microfluidic devices market size, by country 2013-2019 (USD million)
  • TABLE 48 The Asian microfluidic devices market size, by country 2009-2012 (USD million)
  • TABLE 49 The Asian microfluidic devices market size, by country 2013-2019 (USD million)
  • TABLE 50 Roche Diagnostics major product categories
  • TABLE 51 Abbott Laboratories major product categories
  • TABLE 52 Siemens Healthcare major product categories
  • TABLE 53 Agilent Technologies major product categories
  • TABLE 54 Major Fluidigm Corporation products and its application
  • TABLE 55 Major Bio-Rad laboratories products and categories
  • TABLE 56 Major Cepheid products and categories
  • TABLE 57 Major RainDance Technologies products and its applications
  • TABLE 58 Major Dolomite Centre products and categories
  • TABLE 59 Major Micronit Microfluidics products and categories
  • TABLE 60 Major Johnson & Johnson segments and products
  • TABLE 61 Major Becton, Dickinson and Company segments and products
Back to Top